0001140361-18-019858.txt : 20180426 0001140361-18-019858.hdr.sgml : 20180426 20180426203800 ACCESSION NUMBER: 0001140361-18-019858 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180226 FILED AS OF DATE: 20180426 DATE AS OF CHANGE: 20180426 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAFFI ROBERT CENTRAL INDEX KEY: 0001274826 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 18780590 MAIL ADDRESS: STREET 1: C/O BIOMARIN PHARMACEUTICAL INC. STREET 2: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 4/A 1 doc1.xml FORM 4/A X0306 4/A 2018-02-26 2018-02-28 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001274826 BAFFI ROBERT C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 EVP, Technical Operations Common Stock 2018-02-26 2018-02-26 4 A 0 12274 0 A 81168 D Transaction Date is the date that the Issuer's Board of Directors' Compensation Committee Chair certified that the reporting person earned the Restricted Stock Units (RSUs), which are convertible into shares of the Issuer's Common Stock on a 1:1 basis. Represents the total number of RSUs earned pursuant to a calculation set forth in the performance-based RSU awards previously granted under the Issuer's 2006 Share Incentive Plan based on the level of the Issuer's total adjusted net product revenues for the fiscal year ended December 31, 2017 as set forth in the Issuer's audited financial statements. Although earned, the RSUs only vest according to the following schedule: 1/3 vests on each of March 22, 2018, 2019 and 2020, so long as the reporting person remains continuously employed with the Issuer through that date, subject to earlier vesting upon certain events. This amendment is being filed solely to correct an administrative error in the original filing regarding the number of RSUs reported as earned. Amount of securities beneficially owned has been updated from the reporting person's prior report to: a) exclude 55,663 shares reported in the Form 4 Amendment filed with the S.E.C. on 10/13/2017; and b) exclude 4,526 shares inadvertently included in prior reports based on a reconciliation with the Company's records. /s/ Laura Randall Woodhead, Attorney-in-Fact 2018-04-26